Launched in 2024, Morpho represents the new brand identity of Alfasigma’s CDMO (Contract Development and Manufacturing Organisation). Inspired by the ancient Greek word meaning to shape and transform, Morpho embodies our commitment to excellence in transforming raw materials into high-quality pharmaceutical products.
With over 60 years of expertise and a strong international network across Europe and the USA, Morpho adopts a customer-centric approach, managing third-party production with the same care and high standards applied to Alfasigma’s own branded products.
What Sets Us Apart
Why partner with Morpho
Customer-centric approach
Morpho adopts a customer-centric approach, managing third-party production with the same care and high standards it applies to Alfasigma's own branded products.
Integrated tech approach
An integrated approach combining both development and manufacturing capabilities, ensuring flexibility, efficiency and innovation throughout the entire pharmaceutical value chain.
Tailored high-quality services
This comprehensive model allows Morpho to support customers from formulation development to the production of commercial batches, for a wide range of pharmaceutical forms, providing tailored, high-quality services that meet specific client needs.
Firewall and IP segregation
Morpho employs a pragmatic approach to IP and Know-How segregation to ensure maximum protection of client data.
Three divisions, one integrated vision
Tech-driven specialty CDMO
Morpho intends to be recognised as a leading tech-driven specialty CDMO belonging to a global pharmaceutical company, focused on value-added development and manufacturing technologies.
Its three divisions are:
PharmaTech
Fine Chemicals (Biosint)
Dietary Supplements & Medical Food (US)
Together, they provide end-to-end pharmaceutical and nutraceutical solutions tailored to meet the specific needs of partners worldwide.
MORPHO IN A NUTSHELL
Morpho’s capabilities span a wide range of pharmaceutical forms – including sterile injectables, vaccines, oral solids, semi-solids and more – supported by advanced formulation research, clinical batch preparation, and process validation services.
Morpho’s development and manufacturing network offers specialised capabilities to meet a wide range of pharmaceutical, medical foods, and dietary supplements needs, with strategic locations across Europe and the USA.
